69 results on '"Aoki Masashi"'
Search Results
2. Stochastic models for the onset and disease course of multiple sclerosis
3. Dynamic changes in patient admission and their disabilities in multiple sclerosis and neuromyelitis optica: A Japanese nationwide administrative data study
4. The necessity to improve disaster preparedness among patients with amyotrophic lateral sclerosis and their families
5. Referral odyssey plot to visualize causes of surgical delay in mesial temporal lobe epilepsy with hippocampal sclerosis
6. Associations between neuromyelitis optica spectrum disorder, Sjögren's syndrome, and conditions with electrolyte disturbances
7. CGG repeat expansion in LRP12 in amyotrophic lateral sclerosis
8. Efficacy of oligodendrocyte precursor cells as delivery vehicles for single-chain variable fragment to misfolded SOD1 in ALS rat model
9. SQSTM1, a protective factor of SOD1-linked motor neuron disease, regulates the accumulation and distribution of ubiquitinated protein aggregates in neuron
10. Mutation screening of the DNAJC7 gene in Japanese patients with sporadic amyotrophic lateral sclerosis
11. A web-based questionnaire survey on the influence of coronavirus disease-19 on the care of patients with muscular dystrophy
12. CH50 as a putative biomarker of eculizumab treatment in neuromyelitis optica spectrum disorder
13. Seasonal variation of onset in patients with anti-aquaporin-4 antibodies and anti-myelin oligodendrocyte glycoprotein antibody
14. Hybrid Assistive Limb® for sporadic inclusion body myositis: A case series
15. An Amyotrophic Lateral Sclerosis-Associated Mutant of C21ORF2 Is Stabilized by NEK1-Mediated Hyperphosphorylation and the Inability to Bind FBXO3
16. Repeated follow-up of AQP4-IgG titer by cell-based assay in neuromyelitis optica spectrum disorders (NMOSD)
17. Preoperative risks of post-operative myasthenic crisis (POMC): A meta-analysis
18. Ropinirole hydrochloride remedy for amyotrophic lateral sclerosis – Protocol for a randomized, double-blind, placebo-controlled, single-center, and open-label continuation phase I/IIa clinical trial (ROPALS trial)
19. Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial
20. Reduced histone H3K4 trimethylation in oral mucosa of patients with DYT-KMT2B
21. Subclinical retinal atrophy in the unaffected fellow eyes of multiple sclerosis and neuromyelitis optica
22. Genetic generalized epilepsy with catecholaminergic polymorphic ventricular tachycardia complicated by ryanodine receptor 2 variant: A case report
23. Whole brain and grey matter volume of Japanese patients with multiple sclerosis
24. Genetic and functional analysis of KIF5A variants in Japanese patients with sporadic amyotrophic lateral sclerosis
25. Different etiologies and prognoses of optic neuritis in demyelinating diseases
26. Lesion length of optic neuritis impacts visual prognosis in neuromyelitis optica
27. Novel clinical grading of delayed neurologic sequelae after carbon monoxide poisoning and factors associated with outcome
28. Phase 1/2a clinical trial in ALS with ropinirole, a drug candidate identified by iPSC drug discovery
29. Cerebrospinal fluid CXCL13 is a prognostic marker for aseptic meningitis
30. Postural leg tremor in X-linked spinal and bulbar muscular atrophy
31. Identification of the Degradation Products of the Steroid Sulfatase Inhibitor KW-2581 in Jet Mill-Micronized Powder
32. Follow-up of retinal thickness and optic MRI after optic neuritis in anti-MOG antibody-associated disease and anti-AQP4 antibody-positive NMOSD
33. Frequency and characteristics of the TBK1 gene variants in Japanese patients with sporadic amyotrophic lateral sclerosis
34. “Caterpillar sign” in corpus callosum associated with curvilinear pericallosal lipoma in MRI: A case report
35. Comprehensive targeted next-generation sequencing in Japanese familial amyotrophic lateral sclerosis
36. Occurrence of basophilic inclusions and FUS-immunoreactive neuronal and glial inclusions in a case of familial amyotrophic lateral sclerosis
37. Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study): a multicentre, randomised, double-blind, placebo-controlled trial
38. Neuronal NOS is dislocated during muscle atrophy in amyotrophic lateral sclerosis
39. Age at onset influences on wide-ranged clinical features of sporadic amyotrophic lateral sclerosis
40. Next-generation sequencing of 28 ALS-related genes in a Japanese ALS cohort
41. Severe symptoms of 16q-ADCA coexisting with SCA8 repeat expansion
42. A dopamine receptor antagonist L-745,870 suppresses microglia activation in spinal cord and mitigates the progression in ALS model mice
43. Radiological findings in siblings with dysferlin mutation with diverse phenotype
44. Gender difference in association between polymorphism of serotonin transporter gene regulatory region and anxiety
45. NEDL1, a Novel Ubiquitin-protein Isopeptide Ligase for Dishevelled-1, Targets Mutant Superoxide Dismutase-1
46. TARDBP p.G376D mutation, found in rapid progressive familial ALS, induces mislocalization of TDP-43
47. A rare case of sporadic inclusion body myositis and rheumatoid arthritis exhibiting ectopic lymphoid follicle-like structures: a case report and literature review
48. Establishment of a local cooling model against spinal cord ischemia representing prolonged induction of heat shock protein
49. Tardily accelerated neurologic deterioration in two-step thallium intoxication
50. Unilateral loss of oculocephalic response in a patient with hemispheric cerebral hemorrhage
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.